Unibest

Pharmaceutical intermediates

Elobixibat Intermediates

5 pharmaceutical intermediates for Elobixibat. Indication: Constipation.

提交项目All intermediates

About Elobixibat

Originator
AstraZeneca
Indication
Constipation
Approved Date
06/24/2015

Available intermediates

5 intermediates currently listed for Elobixibat. Request specifications, documentation or a quotation for any item below.

Elobixibat intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
1,5-Benzothiazepin-8-ol, 3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-5-phenyl-, 1,1-dioxide439088-16-1//
(R)-tert-butyl 2-(2-(benzyloxycarbonylaMino)-2-phenylacetaMido)acetate439088-73-0//
2-(Bromomethyl)-2-butylhexanoic acid100048-86-0//
7-bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one439089-27-7//
(R)-α-[N-(t-butoxycarbonylmethyl) carbamoyl]benzylamine439088-74-1//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantEltrombopagEltrombopag OlamineEluxadoline

Building toward Elobixibat?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →